Patent Law Weblog
recent posts
- USPTO and DOJ Statement of Interest in Collision Communications: Another Thumb on the Scale in Favor of NPE Patent Plaintiffs
- Oasis Tooling, Inc. v. Siemens Industry Software Inc. (Fed. Cir. 2026)
- Why AI Will Not Take Over the World
- BioNTech Sues Moderna over mRNA Vaccine Technology
- CNIPA Issues Letter on Identity of Foreign Inventors
about
Month: March 2014
-
March 20, 2014 – "Parallel Patent Proceedings Before the PTAB and Federal Court Post-AIA — Navigating Litigation Stays, Discovery and Settlements Concurrent with PTAB Review" (Strafford) – 1:00 to 2:30 pm (EST) March 20, 2014 – "New USPTO Examination Guidelines for Myriad and Mayo" (Intellectual Property Owners Association) – 2:00 to 3:00 pm (ET) March…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar on the "New USPTO Examination Guidelines for Myriad and Mayo" on March 20, 2014 beginning at 2:00 pm (ET). A panel consisting of Courtenay Brinckerhoff of Foley & Lardner; Duane Marks of Roche; and Raul Tamayo, senior legal advisor in the U.S. Patent and…
-
By Michael Borella and Andrew Williams — On March 8th, The Economist published an article deriding both so-called "patent trolls" and "software patents" as being impediments to innovation in the United States. Unfortunately, as we have seen all too often when the mainstream media discusses the patent system, the article contains unsupported assertions, draws questionable…
-
By Donald Zuhn — In an interim rule published in the Federal Register last week (79 Fed. Reg. 12386), the U.S. Patent and Trademark Office indicated that the time periods for meeting certain requirements for filing a request for Track I prioritized examination could be expanded while maintaining the Office's ability to timely examine the…
-
By Kevin E. Noonan — In a 106-page opinion, U.S. District Court Judge Robert J. Shelby on Monday denied Myriad Genetics motion for preliminary injunction in Myriad Genetics v. Ambry Genetics. Characteristic of its aggressive defense of its patent rights, the motion was, as the District Court noted, for "extraordinary" relief and thus not routine…
-
By Michael Borella — In a previous article, we discussed the background of this case, and provided an overview of the Petitioner Brief of patentee Alice Corp. In this article, we continue by covering the brief of the Respondent, CLS Bank. The Supreme Court is scheduled to hear oral arguments for this case on March…
-
By Michael Borella — On December 6th, the Supreme Court granted certiorari to a case that presents the question of "[w]hether claims to computer-implemented inventions — including claims to systems and machines, processes, and items of manufacture — are directed to patent-eligible subject matter within the meaning of 35 U.S.C. § 101 as interpreted by…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Allergan, Inc. v. Actavis plc et al.2:14-cv-00188; filed March 6, 2014 in the Eastern District of Texas • Plaintiff: Allergan, Inc.• Defendants: Actavis plc; Actavis, Inc.; Watson Laboratories, Inc.; Actavis Pharma, Inc. Infringement of…
-
March 12-13, 2014 – FDA Boot Camp*** (American Conference Institute) – New York, NY March 13, 2014 – "Patent Term Adjustments and Extensions: Leveraging Exelixis, Novartis, Other Decisions, and USPTO Rule Changes" (Strafford) – 1:00 to 2:30 pm (EST) March 13, 2014 – "Inter Partes Review: Nuts & Bolts" (Intellectual Property Owners Association) – 2:00…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Inter Partes Review: Nuts & Bolts" on March 13, 2014 beginning at 2:00 pm (ET). A panel consisting of R. Danny Huntington of Rothwell, Figg, Ernst & Manbeck, P.C.; Lori Gordon of Sterne, Kessler, Goldstein & Fox P.L.L.C.; and Judge Michael Tierney of…
Patent Docs 